BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Horvath A, Folhoffer A, Lakatos PL, Halász J, Illyés G, Schaff Z, Hantos MB, Tekes K, Szalay F. Rising plasma nociceptin level during development of HCC: A case report. World J Gastroenterol 2004; 10(1): 152-154 [PMID: 14695788 DOI: 10.3748/wjg.v10.i1.152]
URL: https://www.wjgnet.com/1948-5182/full/v10/i1/152.htm
Number Citing Articles
1
Lubomir Petrov, Elina Tzvetanova, Almira Pavlova, Albena Alexandrova, Rositsa Zamfirova, Margarita Kirkova, Simeon Todorov. In-vivo effects of nociceptin and its structural analogue [Orn9] nociceptin on the antioxidant status of rat blood and liver after carrageenan-induced paw inflammationOpen Medicine 2010; 5(1): 123 doi: 10.2478/s11536-009-0117-3
2
Aldo Spadaro, Antonino Ajello, Carmelo Luigiano, Carmela Morace, Maria Letizia Resta, Grazia Berlinghieri, Salvatore Campo, Claudio Scisca, Angela Alibrandi, Graziella D’arrigo, Nunziata Alessi, Oscar Ferraù, Maria Antonietta Freni. Low utility of plasma Nociceptin/orphanin FQ in the diagnosis of hepatocellular carcinomaWorld Journal of Gastroenterology 2006; 12(29): 4716-4720 doi: 10.3748/wjg.v12.i29.4716
3
Emilia Naydenova, Petar Todorov, Rositza Zamfirova. Nociceptin OpioidVitamins & Hormones 2015; 97: 123 doi: 10.1016/bs.vh.2014.11.005
4
K.M Standifer, C. Simpson-Durand. Reference Module in Biomedical Sciences2016;  doi: 10.1016/B978-0-12-801238-3.99357-7
5
David E. Kaminsky, Thomas J. Rogers. Suppression of CCL2/MCP-1 and CCL5/RANTES Expression by Nociceptin in Human MonocytesJournal of Neuroimmune Pharmacology 2008; 3(2): 75 doi: 10.1007/s11481-007-9086-y
6
Benito Anton, Phillipe Leff, Joseph J. Meissler, Juan C. Calva, Rodolfo Acevedo, Alberto Salazar, Maura Matus, Anabel Flores, Martin Martinez, Martin W. Adler, John P. Gaughan, Toby K. Eisenstein. Nociceptin/Orphanin FQ Suppresses Adaptive Immune Responses In Vivo and at Picomolar Levels In VitroJournal of Neuroimmune Pharmacology 2010; 5(1): 143 doi: 10.1007/s11481-010-9190-2
7
T.A. Barnes, D.G. Lambert. Editorial III: Nociceptin/orphanin FQ peptide-receptor system: are we any nearer the clinic?British Journal of Anaesthesia 2004; 93(5): 626 doi: 10.1093/bja/aeh226
8
Cs Csobay-Novák, P. Sótonyi, M. Krepuska, E. Zima, N. Szilágyi, Sz Tóth, Z. Szeberin, Gy Acsády, B. Merkely, Kornélia Tekes. Decreased plasma nociceptin/orphanin FQ levels after acute coronary syndromesActa Physiologica Hungarica 2012; 99(2): 99 doi: 10.1556/APhysiol.99.2012.2.2
9
Richard J. Bodnar, Gad E. Klein. Endogenous opiates and behavior: 2004Peptides 2005; 26(12): 2629 doi: 10.1016/j.peptides.2005.06.010
10
Miklós Krepuska, Péter Sótonyi, Csaba Csobay-Novák, Zoltán Szeberin, István Hartyánszky, Endre Zima, Nóra Szilágyi, Ferenc Horkay, Béla Merkely, György Acsády, Kornélia Tekes. Plasma nociceptin/orphanin FQ levels are lower in patients with chronic ischemic cardiovascular diseases—A pilot studyRegulatory Peptides 2011; 169(1-3): 1 doi: 10.1016/j.regpep.2011.01.007
11
Diego M. Avella, Eric T. Kimchi, Renee N. Donahue, Hephzibah Rani S. Tagaram, Patricia J. McLaughlin, Ian S. Zagon, Kevin F. Staveley-O'Carroll. The opioid growth factor-opioid growth factor receptor axis regulates cell proliferation of human hepatocellular cancerAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology 2010; 298(2): R459 doi: 10.1152/ajpregu.00646.2009
12
George Notas, Marilena Kampa, Artemissia-Phoebe Nifli, Kostas Xidakis, Despoina Papasava, Kyriaki Thermos, Elias Kouroumalis, Elias Castanas. The inhibitory effect of opioids on HepG2 cells is mediated via interaction with somatostatin receptorsEuropean Journal of Pharmacology 2007; 555(1): 1 doi: 10.1016/j.ejphar.2006.10.018
13
Kaiyuan Wang, Yu Zheng, Yinli Yang, Jian Wang, Baihui Li, Feng Wei, Hongwei Zhao, Xiubao Ren. Nociceptin Receptor Is Overexpressed in Non-small Cell Lung Cancer and Predicts Poor PrognosisFrontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00235